X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (1236) 1236
humans (1134) 1134
kras mutations (955) 955
oncology (870) 870
mutation (829) 829
kras mutation (626) 626
female (621) 621
male (577) 577
middle aged (523) 523
cancer (507) 507
aged (490) 490
colorectal cancer (444) 444
adult (361) 361
genetic aspects (319) 319
ras proteins - genetics (319) 319
colorectal neoplasms - genetics (317) 317
lung neoplasms - genetics (306) 306
prognosis (303) 303
chemotherapy (301) 301
aged, 80 and over (280) 280
egfr (279) 279
proto-oncogene proteins - genetics (275) 275
proto-oncogene proteins p21 (272) 272
pathology (270) 270
tumors (264) 264
lung cancer (251) 251
adenocarcinoma (239) 239
cetuximab (234) 234
growth-factor receptor (232) 232
colorectal neoplasms - pathology (222) 222
metastasis (213) 213
proto-oncogene proteins p21 - genetics (210) 210
gene mutations (206) 206
proto-oncogene proteins b-raf - genetics (195) 195
analysis (193) 193
lung neoplasms - pathology (193) 193
survival (189) 189
braf (186) 186
adenocarcinoma - genetics (184) 184
carcinoma, non-small-cell lung - genetics (180) 180
gefitinib (180) 180
kras (177) 177
receptor, epidermal growth factor - genetics (177) 177
care and treatment (176) 176
biomarkers, tumor - genetics (175) 175
research (174) 174
acquired-resistance (173) 173
microsatellite instability (172) 172
colorectal-cancer (168) 168
neoplasms (163) 163
cell lung-cancer (160) 160
digestive system diseases (160) 160
dna mutational analysis (156) 156
k-ras (152) 152
therapy (151) 151
respiratory system (150) 150
colorectal neoplasms - drug therapy (149) 149
lung neoplasms - drug therapy (147) 147
antineoplastic agents - therapeutic use (144) 144
epidermal growth factor (141) 141
neoplasm staging (141) 141
polymerase chain reaction (137) 137
carcinoma (136) 136
deoxyribonucleic acid--dna (136) 136
article (135) 135
expression (131) 131
patients (129) 129
receptor, epidermal growth factor - antagonists & inhibitors (129) 129
retrospective studies (128) 128
health aspects (126) 126
cell biology (125) 125
kinases (124) 124
cell line, tumor (121) 121
treatment outcome (121) 121
mutation - genetics (120) 120
cancer therapies (119) 119
lung cancer, non-small cell (118) 118
animals (117) 117
adenocarcinoma - pathology (116) 116
resistance (116) 116
egfr mutations (114) 114
non-small cell lung cancer (114) 114
genes (112) 112
k-ras mutations (111) 111
1st-line treatment (110) 110
immunohistochemistry (110) 110
biomarkers (109) 109
carcinoma, non-small-cell lung - drug therapy (108) 108
colon-cancer (107) 107
braf mutation (106) 106
antineoplastic combined chemotherapy protocols - therapeutic use (103) 103
dna (102) 102
metastatic colorectal-cancer (101) 101
gene (100) 100
carcinoma, non-small-cell lung - pathology (98) 98
surgery (98) 98
tyrosine kinase inhibitors (95) 95
diagnosis (94) 94
disease-free survival (93) 93
erlotinib (93) 93
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1707) 1707
French (14) 14
Chinese (10) 10
German (8) 8
Spanish (5) 5
Polish (4) 4
Czech (2) 2
Hungarian (1) 1
Italian (1) 1
Japanese (1) 1
Korean (1) 1
Serbian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


by Kubicka Prof, Stefan and Greil, R and André, T and Bennouna, J and Sastre, J and Van Cutsem, E and Von Moos, R and Österlund, P and Reyes-Rivera, I and Müller, T and Makrutzki, M and Arnold, D and Andel, J and Balcke, P and Benedicic, B and Eisterer, W and Fridrik, M and Jagdt, B and Keil, F and Kretschmer, A and Krippl, P and Oexle, H and Pecherstorfer, M and Samonigg, H and Schmid, M and Thaler, J and Tinchon, C and Weiss, H and Arts, J and De Man, M and Demolin, G and Janssens, J and Polus, M and Benczikova, B and Melichar, B and Prausova, J and Vitek, P and Andersen, F.Z and Jensen, B.B and Keldsen, N and Østerlind, K and Vistisen, K and Elme, A and Magi, A and Ojamaa, K and Ristamäki, R and Salminen, T and Ben Abdelghani, M and Bouche, O and Borg, C and Bouhier-Leporrier, K and Breysacher, G and Chone, L and Clavero Fabri, M.-C and Deplanque, G and Desseigne, F and Dourthe, L.-M and Ezenfis, J and Faroux, R and François, E and Garnier, C and Gaspard, M.-H and Hebbar, M and Illory, J.F and Kaminsky, M.-C and Lecomte, T and Legoux, J.-L and Levache, B and Lobry, C and Lotz, J.-P and Mabro, M and Manet-Lacombe, S and Manfredi, S and Matysiak Budnik, T and Miglianico, L and Mineur, L and Moullet, I and Naman, H and Nouyrigat, P and Oziel-Taieb, S and Perrier, H and Pezet, D and Philip, J and Pottier, V and Porneuf, M and Ramdani, M and Re, D and Rinaldi, Y and Spaeth, D and Taieb, J and Terrebonne, E and Texereau, P and Thirot Bidault, A and Tournigand, C and Tubiana-Mathieu, N and Vantelon, J.-M and Viret, F and Ychou, M and Bangerter, M and Bertram, M.E and ...
Annals of Oncology, ISSN 0923-7534, 09/2013, Volume 24, Issue 9, pp. 2342 - 2349
Journal Article
Molecular Medicine Reports, ISSN 1791-2997, 06/2018, Volume 17, Issue 6, pp. 8061 - 8068
Journal Article
Translational Oncology, ISSN 1936-5233, 2013, Volume 6, Issue 5, pp. 528 - IN1
Abstract Circulating tumor cells (CTCs) provide a readily accessible source of tumor material from patients with cancer. Molecular profiling of these rare... 
Oncology | PATTERNS | ONCOLOGY | COLORECTAL-CANCER | KRAS MUTATION | BLOOD
Journal Article
International Journal of Cancer, ISSN 0020-7136, 05/2019, Volume 144, Issue 9, pp. 2109 - 2117
The incidence of colorectal cancer (CRC) is increasing in China. Here, we aimed to evaluate the latest demographic trends and KRAS/BRAF mutations status of... 
tubular adenocarcinoma | KRAS mutation | colorectal cancer | demographic trends | BRAF mutation
Journal Article
Journal of Cellular Biochemistry, ISSN 0730-2312, 2019, Volume 120, Issue 7, pp. 11690 - 11701
Mutations of the Ras oncogene are frequently detected in human cancers. Among Ras-mediated tumorigenesis, Kras-driven cancers are the most dominant mutation... 
Kras mutation | motility and invasion | V-ATPases | ATP6V0D2 | energy metabolite
Journal Article
Journal of Surgical Research, ISSN 0022-4804, 2019
Background: Mutant KRAS tumors are purported to metastasize differently than wild-type KRAS tumors. The biological heterogeneity of tumors from different parts... 
Location of primary tumors | KRAS mutation | Metastasis | Colorectal cancer
Journal Article
Acta Oncologica, ISSN 0284-186X, 08/2018, Volume 57, Issue 8, pp. 1057 - 1062
Background: Several studies have investigated correlations between metastatic pattern and mutation status in patients with colorectal cancer (CRC). However,... 
PREDICTS | IMPACT | ONCOLOGY | KRAS MUTATION | PATTERNS | RECURRENCE | SPREAD | Index Medicus
Journal Article
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, ISSN 0027-8874, 02/2019, Volume 111, Issue 2, pp. 170 - 179
Background Evidence suggests that diets inducing postprandial hyperinsulinemia may be associated with increased cancer-related mortality. The goal of this... 
MORTALITY | ONCOLOGY | TOTAL-ENERGY-INTAKE | KRAS MUTATION | ADJUVANT TREATMENT | CARBOHYDRATE | PHYSICAL-ACTIVITY | PROTEINS | QUESTIONNAIRE | FLUOROURACIL | ASSOCIATION
Journal Article
Lung Cancer, ISSN 0169-5002, 10/2019, Volume 136, pp. 94 - 97
Invasive mucinous adenocarcinoma (IMA) is a variant of lung adenocarcinoma. We present one case of IMA with mixed mucinous and non-mucinous components,... 
KRAS mutation | Stepwise progression | TP53 mutation | Invasive mucinous adenocarcinoma (IMA) | Index Medicus
Journal Article
Journal of Thoracic Oncology, ISSN 1556-0864, 06/2019, Volume 14, Issue 6, pp. 1095 - 1101
Introduction: KRAS mutation is the most frequent molecular alteration found in advanced NSCLC; it is associated with a poor prognosis without available... 
PD-L1 expression | KRAS mutation | NSCLC | Immunotherapy | ONCOLOGY | RESPIRATORY SYSTEM | NIVOLUMAB | DOCETAXEL
Journal Article
Cancer Management and Research, ISSN 1179-1322, 09/2019, Volume 11, pp. 8337 - 8344
Anthony Turpin,1-3 Michael Genin,4 Mohamed Hebbar,1,2 Florent Occelli,5 Caroline Lanier,5 Francis Vasseur,4 Clotilde Descarpentries,6 Diane Pannier,7 Anne... 
KRAS mutation | Colorectal Cancer | highways | carcinogens | spatial scan statistics
Journal Article
by Fu, XH and Huan, Y and Fan, XJ and Deng, YH and Liu, HL and Zou, HZ and Wu, PH and Chen, ZT and Huang, JL and Wang, JX and Lin, HJ and Huang, SH and Tan, XL and Lan, P and Wang, L and Wang, JP
INTERNATIONAL JOURNAL OF CANCER, ISSN 0020-7136, 05/2019, Volume 144, Issue 9, pp. 2109 - 2117
The incidence of colorectal cancer (CRC) is increasing in China. Here, we aimed to evaluate the latest demographic trends and KRAS/BRAF mutations status of... 
tubular adenocarcinoma | SURVIVAL | KRAS mutation | colorectal cancer | PIK3CA MUTATIONS | RESOLUTION | COLON | demographic trends | BRAF mutation | ONCOLOGY | CURVE ANALYSIS | KRAS | PCR
Journal Article
Journal of Gastrointestinal Surgery, ISSN 1091-255X, 2018, pp. 1 - 7
m-KRAS has been recently reported to be a significant prognostic factor in patients undergoing resection of colorectal liver metastases. This is due to the... 
KRAS mutation | Colorectal liver metastases | Lymphatic system | Metastasis | Gastrointestinal surgery | Liver | Medical prognosis | Colorectal cancer
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 10/2016, Volume 22, Issue 19, pp. 4837 - 4847
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 10/2008, Volume 359, Issue 17, pp. 1757 - 1765
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.